HHS may reconsider blocked 340B rebate pilot after courts halt the program, signaling potential changes for drug discount policies in 2024.

The Trump administration has signaled plans to drop its appeal of a court order that blocked a pilot from changing payment ...

The US Department of Health and Human Services is negotiating with hospital groups about reconsidering a new drug rebate ...

Too many hospitals take advantage of 340B, intended to make medications affordable for low-income patients. A New York proposal would make things worse. Credit: Getty Images. Millions of New Yorkers ...

I am a proud health care professional here in Delaware, and I am calling on leaders in Washington, D.C. to support the 340B ACCESS Act. This legislation is urgently needed to restore accountability to ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

Since 1992, the 340B drug discount program has entitled certain federal grantee clinics and hospitals (called “covered entities”) to purchase outpatient drugs at substantial discounts. The discounted ...

The 340B Drug Pricing Program was designed to help safety net providers serve low-income patients, but it has since ballooned into a multibillion-dollar system dominated by large health systems — with ...

In a move that will fundamentally change how the 340B Drug Pricing Program (“340B Program”) operates for a subset of medications, HRSA’s Office of Pharmacy Affairs (“OPA”) opted late last week to ...

The Trump administration has approved eight drugmakers' rebate plans for a controversial 340B drug discount pilot program that kicks off Jan. 1. The 340B Rebate Model Pilot Program, unveiled this ...

Lawmakers impatient with the lack of progress on a key health care issue — the long-debated need for changes to what’s known as the 340B drug pricing program — say they are closing in on legislation ...